Fidelity Investments’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
Other funds holding ANVS
EAM
Fidelity Investments's ANVS Position: Q2 2026 in Review
Fidelity Investments opened a new position in Annovis Bio (ANVS) in Q2 2026: 610 shares worth $1.14K. The stake represents ﹤0.01% of the portfolio and ranks #5221 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in ANVS as recently as Q2 2024.
Fidelity Investments first reported a position in ANVS in Q2 2024 and has held it in 2 quarters since. The position peaked at $1.15K in Q2 2024. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.
- Fidelity Investments held 610 shares of Annovis Bio worth $1.14K as of Q2 2026.
- Annovis Bio was a new Fidelity Investments position in Q2 2026.
- Annovis Bio made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5221 holding.
- Fidelity Investments first reported a position in Annovis Bio in Q2 2024 and has held it in 2 quarters since.
- Fidelity Investments's Annovis Bio position peaked at $1.15K in Q2 2024.
- 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.